Oyster Point Pharma Inc (OYST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OYST | AZN | AMGN | GILD | VRTX |
| Company | Oyster Point Pharma Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 11.16 | 190.67 | 359.82 | 143.16 | 462.80 |
| High | 11.20 | 190.73 | 360.69 | 143.80 | 463.96 |
| Low | 11.12 | 187.56 | 353.05 | 139.23 | 453.45 |
| Latest | 11.17 | 189.74 | 353.04 | 142.00 | 455.71 |
| Change | +0.02 | -1.55 | -8.09 | -2.40 | -6.78 |
| % Change | +0.18% | -0.81% | -2.24% | -1.66% | -1.47% |
| Volume | 2,088,200 | 610,023 | 974,377 | 1,797,494 | 297,169 |
| 20-Day Average Volume | 306,230 | 1,834,018 | 2,412,586 | 6,167,268 | 1,331,327 |
| Previous Close | 11.15 | 191.29 | 361.13 | 144.40 | 462.49 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 11.13 | 199.00 | 374.50 | 146.91 | 475.78 |
| 20-Day Raw Stochastic | 76.47% | 9.79% | 5.60% | 21.11% | 10.69% |
| 20-Day Relative Strength | 66.58 | 44.03 | 45.08 | 48.24 | 45.84 |
| Weighted Alpha | -44.20 | +28.98 | +17.85 | +35.79 | -3.68 |
| Today's Opinion | 100% Buy | 56% Buy | 56% Buy | 80% Buy | 72% Buy |
| Previous Opinion | 100% Buy | 56% Buy | 80% Buy | 88% Buy | 72% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 12/22/22 | -1.84% since 03/11/26 | -5.94% since 03/11/26 | -2.61% since 03/11/26 | -7.23% since 03/11/26 |
| Low | 11.04 on 12/23/22 | 187.56 on 03/18/26 | 353.05 on 03/18/26 | 139.23 on 03/18/26 | 453.45 on 03/18/26 |
| High | 11.20 on 12/30/22 | 193.96 on 03/17/26 | 375.00 on 03/12/26 | 148.22 on 03/13/26 | 489.97 on 03/12/26 |
| 1-Month | |||||
| %Chg | -0.09% since 11/30/22 | -9.07% since 02/18/26 | -6.46% since 02/18/26 | -6.91% since 02/18/26 | -2.87% since 02/18/26 |
| Low | 11.04 on 12/23/22 | 187.56 on 03/18/26 | 353.05 on 03/18/26 | 139.23 on 03/18/26 | 450.67 on 03/06/26 |
| High | 11.25 on 12/01/22 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 153.26 on 02/20/26 | 507.92 on 03/10/26 |
| 3-Month | |||||
| %Chg | +98.75% since 09/30/22 | +4.71% since 12/18/25 | +9.48% since 12/18/25 | +17.06% since 12/18/25 | +2.10% since 12/18/25 |
| Low | 5.17 on 10/03/22 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 11.83 on 11/07/22 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| 6-Month | |||||
| %Chg | +157.97% since 06/30/22 | +23.10% since 09/18/25 | +28.77% since 09/18/25 | +25.15% since 09/18/25 | +18.00% since 09/18/25 |
| Low | 4.20 on 07/07/22 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 11.83 on 11/07/22 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 299,847 | 296,673,184 | 194,673,616 | 179,261,184 | 117,488,176 |
| Shares Outstanding, K | 26,844 | 1,550,908 | 539,068 | 1,241,421 | 254,034 |
| Annual Sales | 24,540,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -100,660,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 5,590,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 3,190,000,000 |
| Last Quarter Net Income | -36,750,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,191,100,000 |
| 60-Month Beta | 1.35 | 0.32 | 0.45 | 0.37 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.37 on 11/10/22 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 5.03 on 02/12/26 |
| Latest Earnings Date | 02/23/23 | 05/05/26 | 05/07/26 | 04/23/26 | 05/04/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.96 | 16.76 | 17.82 | 28.39 |